Read + Share
Okada M, Yamasaki S, Nakazato H, Hirahara Y, et al. ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of
Resistance to Targeted Therapy. Cancer Res 2024;84:2792-2805.
PMID: 39228255
|
 |
|
Okada M, Yamasaki S, Nakazato H, Hirahara Y, et al. ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of
Resistance to Targeted Therapy. Cancer Res 2024;84:2792-2805.
PMID: 39228255
|
|
|
|